Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
30.00
-1.18 (-3.78%)
At close: May 1, 2026, 4:00 PM EDT
30.00
0.00 (0.00%)
After-hours: May 1, 2026, 7:59 PM EDT
Viking Therapeutics Market Cap
Viking Therapeutics has a market cap or net worth of $3.48 billion as of May 1, 2026. Its market cap has increased by 34.03% in one year.
Market Cap
3.48B
Enterprise Value
2.87B
1-Year Change
34.03%
Ranking
Category
Stock Price
$30.00
Market Cap Chart
Since April 29, 2015, Viking Therapeutics's market cap has increased from $77.50M to $3.48B, an increase of 4,386.22%. That is a compound annual growth rate of 41.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 3.60B | -9.39% |
| Dec 31, 2025 | 3.98B | -11.32% |
| Dec 31, 2024 | 4.48B | 140.89% |
| Dec 29, 2023 | 1.86B | 158.22% |
| Dec 30, 2022 | 720.90M | 100.31% |
| Dec 31, 2021 | 359.90M | -12.37% |
| Dec 31, 2020 | 410.70M | -29.14% |
| Dec 31, 2019 | 579.60M | 6.02% |
| Dec 31, 2018 | 546.70M | 372.52% |
| Dec 29, 2017 | 115.70M | 382.08% |
| Dec 30, 2016 | 24.00M | -27.27% |
| Dec 31, 2015 | 33.00M | -57.42% |
| Apr 29, 2015 | 77.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kailera Therapeutics | 4.18B |
| Legend Biotech | 4.17B |
| Crinetics Pharmaceuticals | 3.97B |
| Veradermics | 3.92B |
| Travere Therapeutics | 3.82B |
| ACADIA Pharmaceuticals | 3.81B |
| Telix Pharmaceuticals | 3.63B |
| Oruka Therapeutics | 3.44B |